Author(s)

James A. de Lemos, MD, FACC, FAHA

Professor of Medicine, University of Texas Southwestern Medical Center; Cardiology Service Chief, Parkland Memorial Hospital, Dallas, Texas

Disclosures

Disclosure: James de Lemos, MD has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Amgen
Served as a speaker or a member of a speakers bureau for: Abbot Diagnostics

Dr de Lemos does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr de Lemos does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Peter P. Toth, MD, PhD

Director of Preventative Cardiology, CGH Medical Center; Professor of Clinical Family and Community Medicine, University of Illinois, Peoria, Illinois

Disclosures

Disclosure: Peter P. Toth, MD, PhD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Amgen, AstraZeneca, Atherotech, Kowa, Liposcience, Merck & Co., Novartis
Served as a speaker or a member of a speakers' bureau for: Amarin, AstraZeneca, Genzyme, GlaxoSmithKline, Kowa, Merck & Co.

Dr Toth does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Toth does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editors

Douglas Blevins, MD

Scientific Director, Medscape, LLC

Disclosures

Disclosure: Douglas Blevins, MD has disclosed no relevant financial relationships.

Terra M. Sumstine

Medical Editor/Writer, Chichester Associates, Allendale, NJ

Disclosures

Disclosure: Terra M. Sumstine has disclosed no relevant financial relationships.

CME Reviewer(s)

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

CME

A Patient With Chest Discomfort and Dyspnea: How Would You Manage?

Authors: James A. de Lemos, MD, FACC, FAHA; Peter P. Toth, MD, PhD
CME Released: 3/20/2015
THIS ACTIVITY HAS EXPIRED
Valid for credit through: 3/20/2016

Start Activity

Target Audience and Goal Statement

This activity is intended for cardiologists.

The goal of this activity is to test and improve the clinician's ability to choose appropriate tests, diagnoses, and treatments in various clinical scenarios for patients with chest discomfort and dyspnea.

Upon completion of this activity, participants will be able to:

Evaluate the patient complaining of dyspnea and differentially diagnose the root cause of chest discomfort and dyspnea
Develop a treatment plan tailored for patients with chest discomfort and dyspnea based on assessment of risk and root cause

Author(s)

James A. de Lemos, MD, FACC, FAHA

Professor of Medicine, University of Texas Southwestern Medical Center; Cardiology Service Chief, Parkland Memorial Hospital, Dallas, Texas

Disclosures

Disclosure: James de Lemos, MD has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Amgen
Served as a speaker or a member of a speakers bureau for: Abbot Diagnostics

Dr de Lemos does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr de Lemos does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Peter P. Toth, MD, PhD

Director of Preventative Cardiology, CGH Medical Center; Professor of Clinical Family and Community Medicine, University of Illinois, Peoria, Illinois

Disclosures

Disclosure: Peter P. Toth, MD, PhD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Amgen, AstraZeneca, Atherotech, Kowa, Liposcience, Merck & Co., Novartis
Served as a speaker or a member of a speakers' bureau for: Amarin, AstraZeneca, Genzyme, GlaxoSmithKline, Kowa, Merck & Co.

Dr Toth does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Toth does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editors

Douglas Blevins, MD

Scientific Director, Medscape, LLC

Disclosures

Disclosure: Douglas Blevins, MD has disclosed no relevant financial relationships.

Terra M. Sumstine

Medical Editor/Writer, Chichester Associates, Allendale, NJ

Disclosures

Disclosure: Terra M. Sumstine has disclosed no relevant financial relationships.

CME Reviewer(s)

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statements

For Physicians

Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

processing....

ABOUT THIS ACTIVITY
Enhance your clinical skills as you engage with patients in an objective and realistic interactive simulation. Treat patients, diagnose medical conditions, and prescribe medications. There are no limits to your choices—order from thousands of labs, diagnoses, devices, and drugs using an intuitive patient chart-based interface.

Powerful metrics track your performance and provide instant expert feedback on your decisions. Upon completion, results will be presented, along with author commentary on each case.

Continue »

Page 1 of 3

CME Information

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or companies that support educational programming on medscape.org. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Faculty and Disclosures

Author(s)

James A. de Lemos, MD, FACC, FAHA

Peter P. Toth, MD, PhD

Editors

Douglas Blevins, MD

Terra M. Sumstine

CME Reviewer(s)

Nafeez Zawahir, MD

Peer Reviewer

CME

A Patient With Chest Discomfort and Dyspnea: How Would You Manage?

Target Audience and Goal Statement

Author(s)

James A. de Lemos, MD, FACC, FAHA

Peter P. Toth, MD, PhD

Editors

Douglas Blevins, MD

Terra M. Sumstine

CME Reviewer(s)

Nafeez Zawahir, MD

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

A Patient With Chest Discomfort and Dyspnea: How Would You Manage?